Navigation Links
Springer to publish the Cerebellum
Date:3/27/2008

Springer and the Society for Research on the Cerebellum (SRC) will partner to publish the journal The Cerebellum with effect from Volume 7, March 2008. The journal represents a significant and original addition to Springers neuroscience portfolio.

The Cerebellum is a quarterly, international journal devoted to the science of the cerebellum and its role in ataxia and other medical disorders. Areas of particular interest include fundamental neurosciences (including molecular and cellular biology), behavioral neurosciences and neurochemistry, genetics, fundamental and clinical neurophysiology, neurology and neuropathology, cognition and neuroimaging.

Editor-in-Chief Mario Manto of the Universit Libre de Bruxelles said, The cerebellum contains more neurons than all the other regions of the brain. As a result of the ageing population, diseases associated with cerebellar dysfunction are becoming more widespread. The Cerebellum offers a forum for the vast amount of scientific research being done in this area. Springers publishing expertise will help to further enhance the journals profile and availability.

Ann Avouris, Publishing Editor, Biomedical Sciences, at Springer, said, Springer is pleased to welcome The Cerebellum to its neuroscience journals program. Our online information platform SpringerLink, with features such as Online First, Cross Reference Linking and Table of Content Alerts, will ensure that readers are kept fully up to date in this crucial and rapidly growing area of research.

The Cerebellum publishes reviews, original research, short communications, opinion and controversies, case studies, meeting reports and book reviews. Springer offers authors, editors and reviewers the use of a fully web-enabled online manuscript submission and review system. This system gives users the option of tracking the progress of the review process of manuscripts in real time. In addition, all authors, via the Springer Open Choice program, have the option of publishing their articles using the open access publishing model.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Related medicine news :

1. Springer to publish new journal focusing on ethical issues in neuroscience
2. Springer to publish International Journal of Hematology
3. Springer to launch new journal in emergency medicine
4. Springer to publish new society journal in cardiology
5. Springer launches Springer Protocols
6. Springer publishes La Chirurgia degli Organi de Movimento
7. Springer founds new electronic journal Head and Neck Pathology
8. Springer launches new journal in musculoskeletal medicine
9. Springer to publish Sports Engineering
10. Springer adds Advances in Therapy to journals portfolio
11. eMPR Digital Drug Reference Reaches 50,000 Downloads and the Publisher Launches a Raffle for Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
Breaking Medicine Technology: